Mitsubishi UFJ Asset Management Co. Ltd. Invests $34.73 Million in The Cooper Companies, Inc. $COO

Key Points

• Mitsubishi UFJ Asset Management acquired 484,342 shares of Cooper Companies worth approximately $34.7 million, giving it a 0.25% stake. Institutional investors and hedge funds collectively own 24.39% of the company.
• Analyst sentiment is mixed: Cooper Companies has an average “Hold” rating and an average price target of $81.64, with targets ranging from $61 to $85 and ratings spanning Strong Buy to Sell.
• The company exceeded quarterly expectations, reporting $1.21 in adjusted EPS versus a $1.10 consensus estimate and $1.08 billion in revenue, up 7.9% year over year. Shares recently opened at $76.73, compared with a 12-month range of $58.89 to $89.83.

Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 484,342 shares of the medical device company's stock, valued at approximately $34,732,000. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.25% of Cooper Companies at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Avalon Trust Co purchased a new stake in Cooper Companies in the second quarter valued at about $25,000. Root Financial Partners LLC grew its stake in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after acquiring an additional 162 shares during the last quarter. SJS Investment Consulting Inc. increased its holdings in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock valued at $26,000 after acquiring an additional 187 shares in the last quarter. Elevation Wealth Partners LLC increased its holdings in shares of Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after acquiring an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp purchased a new position in shares of Cooper Companies in the 2nd quarter valued at approximately $32,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

COO has been the subject of a number of recent analyst reports. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research note on Wednesday, May 27th. KeyCorp restated a "sector weight" rating on shares of Cooper Companies in a research note on Friday, June 5th. Robert W. Baird decreased their price target on shares of Cooper Companies from $98.00 to $85.00 and set an "outperform" rating for the company in a report on Friday, June 5th. Citigroup reiterated a "neutral" rating and set a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Finally, Weiss Ratings lowered Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research note on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat, Cooper Companies currently has an average rating of "Hold" and an average price target of $81.64.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $76.73 on Thursday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company's 50 day moving average is $71.59 and its 200 day moving average is $71.16. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The company has a market cap of $14.96 billion, a PE ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts' expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business's quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source